Middle East Pharmaceutical Industries Company (4016.SR) — Balance sheet
Assets, liabilities, and shareholders' equity for Middle East Pharmaceutical Industries Company — annual and quarterly history.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | 34↑51.8% | 23↑49.9% | 15↓36.5% | 24↑25.0% | 19 | |
| Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash & Short-Term Investments | 34↑51.8% | 23↑49.9% | 15↓36.5% | 24↑25.0% | 19 | |
| Net Receivables | 257↑18.1% | 217↑39.8% | 156↓1.1% | 157↓5.9% | 167 | |
| Accounts Receivable | 257↑18.1% | 217↑39.8% | 156↑2.6% | 152↓7.8% | 164 | |
| Other Receivables | 0.00 | 0.00 | 0.00↓100.0% | 6↑110.5% | 3 | |
| Inventory | 104↑10.6% | 94↑7.4% | 87↓16.9% | 105↑35.5% | 77 | |
| Prepaid Assets | 0.00↓100.0% | 22↑510.9% | 4↑4.2% | 3↑12.0% | 3 | |
| Other Current Assets | 19↑1851617.8% | -0.00↓100.0% | 16↑30.2% | 13↑51.6% | 8 | |
| Total Current Assets | 413↑16.3% | 355↑28.0% | 278↓4.8% | 291↑8.2% | 269 | |
| Property, Plant & Equipment | 124↑2.6% | 121↑1.4% | 119↑12.5% | 106↑2.3% | 103 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 62↑23.3% | 51↑8.0% | 47↑12.9% | 41↑21.0% | 34 | |
| Goodwill & Intangible Assets | 62↑23.3% | 51↑8.0% | 47↑12.9% | 41↑21.0% | 34 | |
| Long-Term Investments | 0.00 | 0.00↓100.0% | 1↓63.3% | 4↓63.3% | 10 | |
| Tax Assets | 0.00 | 0.00 | 0.00↑100.0% | -41↓21.0% | -34 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00↓100.0% | 41↑21.0% | 34 | |
| Total Non-Current Assets | 186↑8.7% | 171↑2.5% | 167↑10.8% | 151↑2.3% | 148 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Assets | 600↑13.8% | 527↑18.4% | 445↑0.6% | 442↑6.1% | 417 | |
| Liabilities | ||||||
| Total Payables | 52↑89.1% | 27↓18.3% | 33↓11.8% | 38↑16.0% | 33 | |
| Accounts Payable | 44↑61.0% | 27↓2.5% | 28↓26.1% | 38↑16.0% | 33 | |
| Other Payables | 8 | 0.00↓100.0% | 5 | 0.00 | 0.00 | |
| Accrued Expenses | 0.00 | 0.00↓100.0% | 14↑73.0% | 8↑12.7% | 7 | |
| Short-Term Debt | 42↓35.4% | 65↑15.7% | 57↓25.0% | 75↑6.0% | 71 | |
| Current Lease Obligations | 0.00 | 0.00 | 0.00↓100.0% | 2↑136.1% | -5 | |
| Tax Payables | 0.00 | 0.00↓100.0% | 5↓2.9% | 6↑16.6% | 5 | |
| Deferred Revenue | 0.00 | 0.00↓100.0% | 4↑250.0% | 1↓75.6% | 5 | |
| Other Current Liabilities | 38↓7.7% | 41↑704.3% | 5↓42.7% | 9↑487.8% | 2 | |
| Total Current Liabilities | 132↓1.5% | 134↑18.4% | 113↓14.0% | 132↑12.1% | 117 | |
| Long-Term Debt | 21 | 0.00↓100.0% | 3↓66.7% | 10↓40.0% | 16 | |
| Non-Current Lease Obligations | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 30↑21.0% | 25↑11.0% | 22↑4.8% | 21↑26.9% | 17 | |
| Total Non-Current Liabilities | 51↑108.9% | 25↓2.9% | 25↓17.4% | 31↓5.8% | 32 | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Lease Obligations | 0.16 | 0.00 | 0.00↓100.0% | 2↑136.1% | -5 | |
| Total Liabilities | 183↑15.6% | 159↑14.5% | 138↓14.6% | 162↑8.2% | 150 | |
| Equity | ||||||
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock | 200↑0.0% | 200↑0.0% | 200↑0.0% | 200↑233.3% | 60 | |
| Retained Earnings | 230↑27.8% | 180↑35.2% | 133↑67.6% | 79↓60.7% | 202 | |
| Additional Paid-In Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accumulated Other Comprehensive Income | -14↓16.8% | -12↑55.9% | -27↓3083.6% | 0.89↓81.6% | 5 | |
| Other Stockholders' Equity | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 19 | |
| Total Stockholders' Equity | 416↑13.0% | 368↑20.2% | 306↑9.3% | 280↑4.9% | 267 | |
| Total Equity | 416↑13.0% | 368↑20.2% | 306↑9.3% | 280↑4.9% | 267 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities & Equity | 600↑13.8% | 527↑18.4% | 445↑0.6% | 442↑6.1% | 417 | |
| Balance Sheet Summary | ||||||
| Total Investments | 0.00 | 0.00↓100.0% | 1↓63.3% | 4↓63.3% | 10 | |
| Total Debt | 64↓2.5% | 65↑9.5% | 60↓29.7% | 85↓2.4% | 87 | |
| Net Debt | 29↓31.2% | 43↓4.1% | 45↓27.0% | 61↓10.0% | 68 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.